Biology of Blood and Marrow Transplantation
Volume 14, Issue 6 , Pages 685-692 , June 2008

Allogeneic Hematopoietic Cell Transplantation in Children with Relapsed Acute Lymphoblastic Leukemia Isolated to the Central Nervous System

  • Paul D. Harker-Murray

      Affiliations

    • Pediatric Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Avis J. Thomas

      Affiliations

    • Pediatric Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota
    • ,
  • John E. Wagner

      Affiliations

    • Pediatric Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Daniel Weisdorf

      Affiliations

    • Adult Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Xianghua Luo

      Affiliations

    • Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Todd E. DeFor

      Affiliations

    • Pediatric Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota
    • Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Michael R. Verneris

      Affiliations

    • Pediatric Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Kathryn E. Dusenbery

      Affiliations

    • Department of Therapeutic Radiology/Radiation Oncology, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Margaret L. MacMillan

      Affiliations

    • Pediatric Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Jakub Tolar

      Affiliations

    • Pediatric Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota
    • ,
  • K. Scott Baker

      Affiliations

    • Pediatric Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota
    • ,
  • Paul J. Orchard

      Affiliations

    • Pediatric Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota
    • Corresponding Author InformationCorrespondence and reprint requests: Paul J. Orchard, MD, Pediatric Hematology, Oncology, Blood and Marrow Transplantation, University of Minnesota Medical Center, Fairview, Mayo Mail Code 366, 420 Delaware Street SE, Minneapolis, MN 55455.

Received 4 October 2007 ,Accepted 24 March 2008.

References 

  1. Pui CH. Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment. Hematology Am Soc Hematol Educ Program. 2006;142–146
  2. Nguyen K, Cheng S-C, Raetz E, et al. Factors influencing survival after relapse from childhood ALL: a Children's Oncology Group Study. ASH Ann Meet Abstr. 2006;108:1855
  3. Hutchinson RJ, Gaynon PS, Sather H, et al. Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881. J Clin Oncol. 2003;21:1790–1797
  4. Bostrom BC, Sensel MR, Sather HN, et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood. 2003;101:3809–3817
  5. Lange BJ, Bostrom BC, Cherlow JM, et al. Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood. 2002;99:825–833
  6. Ritchey AK, Pollock BH, Lauer SJ, Andejeski Y, Barredo J, Buchanan GR. Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study. J Clin Oncol. 1999;17:3745–3752
  7. Barredo JC, Devidas M, Lauer SJ, et al. Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study. J Clin Oncol. 2006;24:3142–3149
  8. Barker JN, Hough RE, van Burik JA, et al. Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source. Biol Blood Marrow Transplant. 2005;11:362–370
  9. Davies SM, Wagner JE, Shu XO, et al. Unrelated donor bone marrow transplantation for children with acute leukemia. J Clin Oncol. 1997;15:557–565
  10. McGlave PB, Shu XO, Wen W, et al. Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program. Blood. 2000;95:2219–2225
  11. Ramsay NK, Kim TH, McGlave P, et al. Total lymphoid irradiation and cyclophosphamide conditioning prior to bone marrow transplantation for patients with severe aplastic anemia. Blood. 1983;62:622–626
  12. McGlave P, Arthur D, Haake R, et al. Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantation. J Clin Oncol. 1987;5:1033–1040
  13. Kersey JH, Weisdorf D, Nesbit ME, et al. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. N Engl J Med. 1987;317:461–467
  14. Kim TH, McGlave PB, Ramsay N, et al. Comparison of two total body irradiation regimens in allogeneic bone marrow transplantation for acute non-lymphoblastic leukemia in first remission. Int J Radiat Oncol Biol Phys. 1990;19:889–897
  15. Barker JN, Davies SM, DeFor T, Ramsay NK, Weisdorf DJ, Wagner JE. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood. 2001;97:2957–2961
  16. Wagner JE, Rosenthal J, Sweetman R, et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood. 1996;88:795–802
  17. Lin DY. Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med. 1997;16:901–910
  18. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc A. 1972;135:185–207
  19. Cox D. Regression models and life-tables. J R Stat Soc B. 1972;34:187–220
  20. Morris EC, Harrison G, Bailey CC, et al. Prognostic factors and outcome for children after second central nervous system relapse of acute lymphoblastic leukaemia. Br J Haematol. 2003;120:787–789
  21. Woolfrey AE, Anasetti C, Storer B, et al. Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children. Blood. 2002;99:2002–2008
  22. Afify Z, Hunt L, Green A, Guttridge M, Cornish J, Oakhill A. Factors affecting the outcome of stem cell transplantation from unrelated donors for childhood acute lymphoblastic leukemia in third remission. Bone Marrow Transplant. 2005;35:1041–1047
  23. Bordigoni P, Esperou H, Souillet G, et al. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Societe Francaise de Greffe de Moelle study. Br J Haematol. 1998;102:656–665
  24. Borgmann A, Baumgarten E, Schmid H, et al. Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative?. Bone Marrow Transplant. 1997;20:939–944
  25. Yoshihara T, Morimoto A, Kuroda H, et al. Allogeneic stem cell transplantation in children with acute lymphoblastic leukemia after isolated central nervous system relapse: our experiences and review of the literature. Bone Marrow Transplant. 2006;37:25–31
  26. Ness KK, Gurney JG. Adverse late effects of childhood cancer and its treatment on health and performance. Annu Rev Public Health. 2007;28:279–302
  27. Alvarez JA, Scully RE, Miller TL, et al. Long-term effects of treatments for childhood cancers. Curr Opin Pediatr. 2007;19:23–31
  28. Butler RW, Haser JK. Neurocognitive effects of treatment for childhood cancer. Ment Retard Dev Disabil Res Rev. 2006;12:184–191
  29. Duffner PK. Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors. Neurologist. 2004;10:293–310
  30. Eapen M, Raetz E, Zhang MJ, et al. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. Blood. 2006;107:4961–4967
  31. Gaynon PS, Qu RP, Chappell RJ, et al. Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse—the Children's Cancer Group Experience. Cancer. 1998;82:1387–1395
  32. Buhrer C, Hartmann R, Fengler R, et al. Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia. Med Pediatr Oncol. 1993;21:470–476

PII: S1083-8791(08)00119-5

doi: 10.1016/j.bbmt.2008.03.011

Biology of Blood and Marrow Transplantation
Volume 14, Issue 6 , Pages 685-692 , June 2008

Article Tools

* Image Usage & Resolution